Coagulation And Metastasis: What Does The Experimental Literature Tell Us?

British Journal of Haematology

Volumn 162, Issue 4, 2013, Pages 433-441

  Gil Bernabé, Ana M ^a   Lucotti, Serena ^a   Muschel, Ruth J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Aspirin; Coagulation; Macrophages; Metastasis; Tissue factor

Indexed keywords

4 HYDROXYCOUMARIN; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 9A; CD11B ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEPARIN; INTERCELLULAR ADHESION MOLECULE 1; LOW MOLECULAR WEIGHT HEPARIN; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4; SIALIDASE; SOMATOMEDIN C; THROMBIN; THROMBIN INHIBITOR; THROMBOPLASTIN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; WARFARIN;

ANTICOAGULATION; BLOOD CLOTTING; BONE METASTASIS; BRAIN CANCER; BRAIN METASTASIS; BREAST CANCER; CANCER CELL; CANCER RISK; CARCINOGENESIS; CELL SPREADING; DRUG MEGADOSE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LIVER METASTASIS; LOW DRUG DOSE; LUNG METASTASIS; MACROPHAGE; MEMBRANE MICROPARTICLE; METASTASIS; METASTASIS POTENTIAL; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PANCREAS CANCER; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; TUMOR GROWTH; TUMOR VASCULARIZATION; VENOUS THROMBOEMBOLISM;

ASPIRIN; COAGULATION; MACROPHAGES; METASTASIS; TISSUE FACTOR;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD PLATELETS; CYSTEINE ENDOPEPTIDASES; CYTOPLASMIC GRANULES; HIRUDINS; HUMANS; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MACROPHAGES; MICE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; NEOPLASTIC CELLS, CIRCULATING; NEURAMINIDASE; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; RATS; THROMBIN; THROMBOPHILIA; THROMBOPLASTIN;

EID: 84880700491     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12381     Document Type: Review

References (96)

1. Agostino, D., Cliffton, E.E. & Girolami, A. (1966) Effect of prolonged coumadin treatment on the production of pulmonary metastases in the rat. Cancer, 19, 284-288.
2. Ahn, Y.S. (2005) Cell-derived microparticles: 'Miniature envoys with many faces'. Journal of Thrombosis and Haemostasis, 3, 884-887.
3. Algra, A.M. & Rothwell, P.M. (2012) Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncology, 13, 518-527.
4. Al-Mehdi, A.B., Tozawa, K., Fisher, A.B., Shientag, L., Lee, A. & Muschel, R.J. (2000) Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nature Medicine, 6, 100-102.
5. Amirkhosravi, A., Meyer, T., Chang, J.Y., Amaya, M., Siddiqui, F., Desai, H. & Francis, J.L. (2002) Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma. Thrombosis and Haemostasis, 87, 930-936.
6. Asanuma, K., Wakabayashi, H., Hayashi, T., Okuyama, N., Seto, M., Matsumine, A., Kusuzaki, K., Suzuki, K. & Uchida, A. (2004) Thrombin inhibitor, argatroban, prevents tumor cell migration and bone metastasis. Oncology, 67, 166-173.
7. Van Den Berg, Y.W., Osanto, S., Reitsma, P.H. & Versteeg, H.H. (2012) The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood, 119, 924-932.
8. Bobek, V. & Kovarik, J. (2004) Antitumor and antimetastatic effect of warfarin and heparins. Biomedicine & Pharmacotherapy, 58, 213-219.
9. Bobek, V., Boubelik, M., Fiserova, A., L'Uptovcova, M., Vannucci, L., Kacprzak, G., Kolodzej, J., Majewski, A.M. & Hoffman, R.M. (2005) Anticoagulant drugs increase natural killer cell activity in lung cancer. Lung Cancer, 47, 215-223.
10. Borsig, L., Wong, R., Feramisco, J., Nadeau, D.R., Varki, N.M. & Varki, A. (2001) Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proceedings of the National Academy of Sciences of the United States of America, 98, 3352-3357.
11. Borsig, L., Wong, R., Hynes, R.O., Varki, N.M. & Varki, A. (2002) Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proceedings of the National Academy of Sciences of the United States of America, 99, 2193-2198.
12. Bosetti, C., Rosato, V., Gallus, S., Cuzick, J. & La Vecchia, C. (2012) Aspirin and cancer risk: a quantitative review to 2011. Annals of Oncology, 23, 1403-1415.
13. Bruggemann, L.W., Versteeg, H.H., Niers, T.M., Reitsma, P.H. & Spek, C.A. (2008) Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders. Journal of Cellular and Molecular Medicine, 12, 2622-2627.
14. Callander, N.S., Varki, N. & Rao, L.V. (1992) Immunohistochemical identification of tissue factor in solid tumors. Cancer, 70, 1194-1201.
15. Camerer, E., Qazi, A.A., Duong, D.N., Cornelissen, I., Advincula, R. & Coughlin, S.R. (2004) Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood, 104, 397-401.
16. Chan, A.T., Arber, N., Burn, J., Chia, W.K., Elwood, P., Hull, M.A., Logan, R.F., Rothwell, P.M., Schror, K. & Baron, J.A. (2012) Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prevention Research (Philadelphia, PA), 5, 164-178.
17. Choe, K.S., Cowan, J.E., Chan, J.M., Carroll, P.R., D'Amico, A.V. & Liauw, S.L. (2012) Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. Journal of Clinical Oncology, 30, 3540-3544.
18. Contrino, J., Hair, G., Kreutzer, D.L. & Rickles, F.R. (1996) In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nature Medicine, 2, 209-215.
19. Coupland, L.A., Chong, B.H. & Parish, C.R. (2012) Platelets and p-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells. Cancer Research, 72, 4662-4671.
20. Donati, M.B. & Lorenzet, R. (2012) Thrombosis and cancer: 40 years of research. Thrombosis Research, 129, 348-352.
21. Ekambaram, P., Lambiv, W., Cazzolli, R., Ashton, A.W. & Honn, K.V. (2011) The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis. Cancer and Metastasis Reviews, 30, 397-408.
22. Erpenbeck, L. & Schon, M.P. (2010) Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood, 115, 3427-3436.
23. Esumi, N., Fan, D. & Fidler, I.J. (1991) Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Research, 51, 4549-4556.
24. Falanga, A., Panova-Noeva, M. & Russo, L. (2009) Procoagulant mechanisms in tumour cells. Best Practice & Research. Clinical Haematology, 22, 49-60.
25. Falanga, A., Tartari, C.J. & Marchetti, M. (2012) Microparticles in tumor progression. Thrombosis Research, 129(Suppl. 1), S132-S136.
26. Falati, S., Liu, Q., Gross, P., Merrill-Skoloff, G., Chou, J., Vandendries, E., Celi, A., Croce, K., Furie, B.C. & Furie, B. (2003) Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. Journal of Experimental Medicine, 197, 1585-1598.
27. Ferjancic, S., Gil-Bernabe, A.M., Hill, S.A., Allen, P.D., Richardson, P., Sparey, T., Savory, E., McGuffog, J. & Muschel, R.J. (2013) VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice. Blood, 121, 3289-3297.
28. Francis, J.L., Biggerstaff, J. & Amirkhosravi, A. (1998) Hemostasis and malignancy. Seminars in Thrombosis and Hemostasis, 24, 93-109.
29. Furie, B. & Furie, B.C. (2008) Mechanisms of thrombus formation. New England Journal of Medicine, 359, 938-949.
30. Garnier, D., Magnus, N., D'Asti, E., Hashemi, M., Meehan, B., Milsom, C. & Rak, J. (2012) Genetic pathways linking hemostasis and cancer. Thrombosis Research, 129(Suppl. 1), S22-S29.
31. Gasic, G.J., Gasic, T.B. & Stewart, C.C. (1968) Antimetastatic effects associated with platelet reduction. Proceedings of the National Academy of Sciences of the United States of America, 61, 46-52.
32. Gay, L.J. & Felding-Habermann, B. (2011) Contribution of platelets to tumour metastasis. Nature Reviews Cancer, 11, 123-134.
33. Gil-Bernabe, A.M., Ferjancic, S., Tlalka, M., Zhao, L., Allen, P.D., Im, J.H., Watson, K., Hill, S.A., Amirkhosravi, A., Francis, J.L., Pollard, J.W., Ruf, W. & Muschel, R.J. (2012) Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. Blood, 119, 3164-3175.
34. Glaves, D. & Weiss, L. (1978) Initial tumor cell arrest in animals of defined coagulative status. International Journal of Cancer, 21, 741-746.
35. Green, D. & Karpatkin, S. (2010) Role of thrombin as a tumor growth factor. Cell Cycle, 9, 656-661.
36. Heit, J.A. (2005) Cancer and venous thromboembolism: scope of the problem. Cancer Control, 12(Suppl. 1), 5-10.
37. Ho-Tin-Noe, B., Goerge, T., Cifuni, S.M., Duerschmied, D. & Wagner, D.D. (2008) Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Research, 68, 6851-6858.
38. Ho-Tin-Noe, B., Demers, M. & Wagner, D.D. (2011) How platelets safeguard vascular integrity. Journal of Thrombosis and Haemostasis, 9(Suppl. 1), 56-65.
39. Hron, G., Kollars, M., Weber, H., Sagaster, V., Quehenberger, P., Eichinger, S., Kyrle, P.A. & Weltermann, A. (2007) Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thrombosis and Haemostasis, 97, 119-123.
40. Hu, L., Lee, M., Campbell, W., Perez-Soler, R. & Karpatkin, S. (2004) Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis. Blood, 104, 2746-2751.
41. Im, J.H., Fu, W., Wang, H., Bhatia, S.K., Hammer, D.A., Kowalska, M.A. & Muschel, R.J. (2004) Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Research, 64, 8613-8619.
42. Kasthuri, R.S., Taubman, M.B. & Mackman, N. (2009) Role of tissue factor in cancer. Journal of Clinical Oncology, 27, 4834-4838.
43. Key, N.S. & Mackman, N. (2010) Tissue factor and its measurement in whole blood, plasma, and microparticles. Seminars in Thrombosis and Hemostasis, 36, 865-875.
44. Kim, Y.J., Borsig, L., Varki, N.M. & Varki, A. (1998) P-selectin deficiency attenuates tumor growth and metastasis. Proceedings of the National Academy of Sciences of the United States of America, 95, 9325-9330.
45. Kim, H.K., Song, K.S., Park, Y.S., Kang, Y.H., Lee, Y.J., Lee, K.R., Ryu, K.W., Bae, J.M. & Kim, S. (2003) Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. European Journal of Cancer, 39, 184-191.
46. Kirstein, J.M., Graham, K.C., Mackenzie, L.T., Johnston, D.E., Martin, L.J., Tuck, A.B., MacDonald, I.C. & Chambers, A.F. (2009) Effect of anti-fibrinolytic therapy on experimental melanoma metastasis. Clinical & Experimental Metastasis, 26, 121-131.
47. Konstantopoulos, K. & McIntire, L.V. (1996) Effects of fluid dynamic forces on vascular cell adhesion. Journal of Clinical Investigation, 98, 2661-2665.
48. Kopp, H.G., Placke, T. & Salih, H.R. (2009) Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Research, 69, 7775-7783.
49. Kozlowski, E.O., Pavao, M.S. & Borsig, L. (2011) Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin. Journal of Thrombosis and Haemostasis, 9, 1807-1815.
50. Labelle, M., Begum, S. & Hynes, R.O. (2011) Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell, 20, 576-590.
51. Laubli, H. & Borsig, L. (2011) Selectins as mediators of lung metastasis. Cancer Microenvironment, 3, 97-105.
52. Manly, D.A., Wang, J., Glover, S.L., Kasthuri, R., Liebman, H.A., Key, N.S. & Mackman, N. (2010) Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. Thrombosis Research, 125, 511-512.
53. Milsom, C. & Rak, J. (2008) Tissue factor and cancer. Pathophysiology of Haemostasis and Thrombosis, 36, 160-176.
54. Milsom, C., Anderson, G.M., Weitz, J.I. & Rak, J. (2007) Elevated tissue factor procoagulant activity in CD133-positive cancer cells. Journal of Thrombosis and Haemostasis, 5, 2550-2552.
55. Mueller, B.M. & Ruf, W. (1998) Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. Journal of Clinical Investigation, 101, 1372-1378.
56. Mueller, B.M., Reisfeld, R.A., Edgington, T.S. & Ruf, W. (1992) Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proceedings of the National Academy of Sciences of the United States of America, 89, 11832-11836.
57. Ngo, C.V., Picha, K., McCabe, F., Millar, H., Tawadros, R., Tam, S.H., Nakada, M.T. & Anderson, G.M. (2007) CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models. International Journal of Cancer, 120, 1261-1267.
58. Nierodzik, M.L., Chen, K., Takeshita, K., Li, J.J., Huang, Y.Q., Feng, X.S., D'Andrea, M.R., Andrade-Gordon, P. & Karpatkin, S. (1998) Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood, 92, 3694-3700.
59. Nieswandt, B., Hafner, M., Echtenacher, B. & Mannel, D.N. (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Research, 59, 1295-1300.
60. Oshima, H. & Oshima, M. (2012) The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. Journal of Gastroenterology, 47, 97-106.
61. Palumbo, J.S. & Degen, J.L. (2007) Mechanisms linking tumor cell-associated procoagulant function to tumor metastasis. Thrombosis Research, 120(Suppl. 2), S22-S28.
62. Palumbo, J.S., Kombrinck, K.W., Drew, A.F., Grimes, T.S., Kiser, J.H., Degen, J.L. & Bugge, T.H. (2000) Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood, 96, 3302-3309.
63. Palumbo, J.S., Talmage, K.E., Massari, J.V., La Jeunesse, C.M., Flick, M.J., Kombrinck, K.W., Jirouskova, M. & Degen, J.L. (2005) Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood, 105, 178-185.
64. Palumbo, J.S., Talmage, K.E., Massari, J.V., La Jeunesse, C.M., Flick, M.J., Kombrinck, K.W., Hu, Z., Barney, K.A. & Degen, J.L. (2007) Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood, 110, 133-141.
65. Paweletz, C.P., Charboneau, L. & Liotta, L.A. (2001) Overview of metastasis assays. Current Protocols in Cell Biology, Chapter 19, Unit 19.11.
66. Qian, B.Z. & Pollard, J.W. (2010) Macrophage diversity enhances tumor progression and metastasis. Cell, 141, 39-51.
67. Qian, B., Deng, Y., Im, J.H., Muschel, R.J., Zou, Y., Li, J., Lang, R.A. & Pollard, J.W. (2009) A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS ONE, 4, e6562.
68. Qian, B.Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L.R., Kaiser, E.A., Snyder, L.A. & Pollard, J.W. (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature, 475, 222-225.
69. Rickles, F.R. (2006) Mechanisms of cancer-induced thrombosis in cancer. Pathophysiology of Haemostasis and Thrombosis, 35, 103-110.
70. Roos, E. & Dingemans, K.P. (1979) Mechanisms of metastasis. Biochimica et Biophysica Acta, 560, 135-166.
71. Rothwell, P.M., Wilson, M., Elwin, C.E., Norrving, B., Algra, A., Warlow, C.P. & Meade, T.W. (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet, 376, 1741-1750.
72. Rothwell, P.M., Fowkes, F.G., Belch, J.F., Ogawa, H., Warlow, C.P. & Meade, T.W. (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet, 377, 31-41.
73. Rothwell, P.M., Price, J.F., Fowkes, F.G., Zanchetti, A., Roncaglioni, M.C., Tognoni, G., Lee, R., Belch, J.F., Wilson, M., Mehta, Z. & Meade, T.W. (2012a) Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet, 379, 1602-1612.
74. Rothwell, P.M., Wilson, M., Price, J.F., Belch, J.F., Meade, T.W. & Mehta, Z. (2012b) Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet, 379, 1591-1601.
75. Ruf, W. & Mueller, B.M. (1996) Tissue factor in cancer angiogenesis and metastasis. Current Opinion in Hematology, 3, 379-384.
76. Ruf, W., Disse, J., Carneiro-Lobo, T.C., Yokota, N. & Schaffner, F. (2011) Tissue factor and cell signalling in cancer progression and thrombosis. Journal of Thrombosis and Haemostasis, 9(Suppl. 1), 306-315.
77. Sabrkhany, S., Griffioen, A.W. & Oude Egbrink, M.G. (2011) The role of blood platelets in tumor angiogenesis. Biochimica et Biophysica Acta, 1815, 189-196.
78. Schaffner, F. & Ruf, W. (2008) Tissue factor and protease-activated receptor signaling in cancer. Seminars in Thrombosis and Hemostasis, 34, 147-153.
79. Schaffner, F., Yokota, N. & Ruf, W. (2012) Tissue factor proangiogenic signaling in cancer progression. Thrombosis Research, 129(Suppl. 1), S127-S131.
80. Shebl, F.M., Sakoda, L.C., Black, A., Koshiol, J., Andriole, G.L., Grubb, R., Church, T.R., Chia, D., Zhou, C., Chu, L.W., Huang, W.Y., Peters, U., Kirsh, V.A., Chatterjee, N., Leitzmann, M.F., Hayes, R.B. & Hsing, A.W. (2012) Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study. British Journal of Cancer, 107, 207-214.
81. St Hill, C.A. (2011) Interactions between endothelial selectins and cancer cells regulate metastasis. Frontiers in Bioscience, 16, 3233-3251.
82. Stewart, C.A., Vivier, E. & Colonna, M. (2006) Strategies of natural killer cell recognition and signaling. Current Topics in Microbiology and Immunology, 298, 1-21.
83. Tilley, R.E., Holscher, T., Belani, R., Nieva, J. & Mackman, N. (2008) Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thrombosis Research, 122, 604-609.
84. Varki, N.M. & Varki, A. (2002) Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans. Seminars in Thrombosis and Hemostasis, 28, 53-66.
85. Veitonmaki, T., Tammela, T.L., Auvinen, A. & Murtola, T.J. (2012) Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level. European Journal of Cancer, 49, 938-945.
86. Versteeg, H.H. & Ruf, W. (2006) Emerging insights in tissue factor-dependent signaling events. Seminars in Thrombosis and Hemostasis, 32, 24-32.
87. Villares, G.J., Zigler, M., Dobroff, A.S., Wang, H., Song, R., Melnikova, V.O., Huang, L., Braeuer, R.R. & Bar-Eli, M. (2011) Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype. Proceedings of the National Academy of Sciences of the United States of America, 108, 626-631.
88. Vrana, J.A., Stang, M.T., Grande, J.P. & Getz, M.J. (1996) Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family. Cancer Research, 56, 5063-5070.
89. Wang, H., Fu, W., Im, J.H., Zhou, Z., Santoro, S.A., Iyer, V., DiPersio, C.M., Yu, Q.C., Quaranta, V., Al-Mehdi, A. & Muschel, R.J. (2004) Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. Journal of Cell Biology, 164, 935-941.
90. Weber, C., Erl, W., Pietsch, A. & Weber, P.C. (1995) Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation, 91, 1914-1917.
91. Yu, J.L., May, L., Lhotak, V., Shahrzad, S., Shirasawa, S., Weitz, J.I., Coomber, B.L., Mackman, N. & Rak, J.W. (2005) Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood, 105, 1734-1741.
92. Zacharski, L.R., Prandoni, P. & Monreal, M. (2005) Warfarin versus low-molecular-weight heparin therapy in cancer patients. Oncologist, 10, 72-79.
93. Zhao, L., Lim, S.Y., Gordon-Weeks, A.N., Tapmeier, T.T., Im, J.H., Cao, Y., Beech, J., Allen, D., Smart, S. & Muschel, R.J. (2013) Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis. Hepatology, 57, 829-839.
94. Zigler, M., Kamiya, T., Brantley, E.C., Villares, G.J. & Bar-Eli, M. (2011) PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Research, 71, 6561-6566.
95. Zwicker, J.I. (2010) Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Thrombosis Research, 125(Suppl. 2), S89-S91.
96. Zwicker, J.I., Liebman, H.A., Neuberg, D., Lacroix, R., Bauer, K.A., Furie, B.C. & Furie, B. (2009) Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clinical Cancer Research, 15, 6830-6840.